Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 43.5 | 62 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 56.0 | 63 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 70.5 | 74 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 82.0 | 63 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 97.0 | 72 | |
N2759 | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 91.0 | 57 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 75.0 | 69 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 92.5 | 70 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 110.0 | 59 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | FGF Basic | 103.0 | 59 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 37.0 | 98 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 46.0 | 77 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 37.5 | 76 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 62.5 | 64 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 42.5 | 80 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 46.0 | 71 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 42.5 | 100 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 61.0 | 62 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 91.0 | 64 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 100.0 | 67 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 105.5 | 76 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 111.0 | 67 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 104.0 | 63 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 98.0 | 76 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | FGF Basic | 107.0 | 65 |